Transplant Organ Genomics to Help Prevent Rejection in Kidney Transplant Recipients – RNA-seq Signature Validation


About this study

The purpose of this study is to validate the use of an RNA-seq based peripheral blood assay in renal transplant recipients in adult kidney transplant recipients.  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Any kidney transplant recipients >18 years of age; living or deceased donors willing and able to undergo peripheral blood collections at the specified time points and willing to participate in follow-up.

Exclusion Criteria

  • Any kidney transplant recipient < 18 years of age.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mark Stegall, M.D.

Closed for enrollment

Contact information:

Leah Majerus

Jacksonville, Fla.

Mayo Clinic principal investigator

Martin Mai, M.D.

Closed for enrollment

Contact information:

Joel Espinoza

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Raymond Heilman, M.D.

Closed for enrollment

Contact information:

Angela Eyshou M.B.A.

(480) 342-6536

More information


Publications are currently not available

Mayo Clinic Footer